Lebenthal Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Lebenthal Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$12.5M	Buy	169,649 +134,057	+377%	+$9.47M	1.55%	7
2016 Q1	$2.27M	Buy	35,592 +9,933	+39%	+$626K	0.4%	75
2015 Q4	$1.76M	Sell	25,659 -3,972	-13%	-$262K	0.41%	97
2015 Q3	$1.75M	Buy	29,631 +3,405	+13%	+$216K	0.4%	97
2015 Q2	$1.74M	Sell	26,226 -556	-2%	-$36.6K	0.36%	127
2015 Q1	$1.73M	Buy	26,782 +519	+2%	+$32.5K	0.41%	103
2014 Q4	$1.55M	Buy	+26,263	New	+$1.48M	0.68%	39

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Lebenthal Holdings's BMY Position: Q2 2016 in Review

Lebenthal Holdings increased its Bristol-Myers Squibb (BMY) stake by 377% in Q2 2016, buying an estimated $9.47M and bringing the position to 169,649 shares worth $12.5M. The position accounts for 1.55% of the portfolio, ranked #7.

Lebenthal Holdings first reported a position in BMY in Q4 2014 and has held it in 7 quarters since. 1,576 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

Lebenthal Holdings held 169,649 shares of Bristol-Myers Squibb worth $12.5M as of Q2 2016.
Lebenthal Holdings bought 134,057 Bristol-Myers Squibb shares in Q2 2016, an estimated $9.47M.
Bristol-Myers Squibb made up 1.55% of Lebenthal Holdings's portfolio in Q2 2016, its #7 holding.
Lebenthal Holdings first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 7 quarters since.
1,576 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.